Observational Study
Copyright ©The Author(s) 2017.
World J Hepatol. Mar 18, 2017; 9(8): 436-442
Published online Mar 18, 2017. doi: 10.4254/wjh.v9.i8.436
Table 1 Demographic, laboratory and liver fibrosis characteristics
CharacteristicsPatients (n = 81)
Gender (male/female)40 (49.4%)/41 (50.6%)
Age (yr) - median (Q1;Q3)51 (30-78)
BMI (kg/m2) - median (Q1;Q3)26.5 (24.3-29.6)
ALT (IU/L) - median (Q1;Q3)50 (32.5-85)
AST (IU /L) - median (Q1;Q3)42 (28.5-61.5)
Platelet count (× 103/mm3) - median (Q1; Q3)202 (148-247)
Histological fibrosis stage, n (%)
F05 (6.2)
F133 (40.7)
F220 (24.7)
F312 (14.8)
F411 (13.6)
TE (kPa) - median (Q1; Q3)6.9 (5-12.2)
TE success rate (mean ± SD)0.92 ± 0.21
CAP (dB/m) - mMedian (Q1; Q3)237 (204-263)
ARFI (m/s) - median (Q1; Q3)1.25 (0.65-2.89)
APRI - median (Q1; Q3)0.66 (0.41-1.29)
FIB-4 - median (Q1; Q3)1.41 (0.90-2.45)
Table 2 Summary of cut-off values, area under de curve, sensitivity, specificity, positive predictive value, negative predictive value and accuracy
MethodAUCAUC CI (95%)SeSpPPVNPVAccuracy
TE (kPa)
> F2 (6.6)0.87160.7953-0.94882.90%77.50%89.30%66.70%80.20%
> F3 (8.9)0.91870.8319-1.00087%86.20%87.30%85.90%86.40%
= F4 (12.2)0.96750.9321-1.000100%87.10%79.30%100%88.90%
ARFI (m/s)
> F2 (1.22)0.77010.6653-0.874978%70%85.50%58.40%74.10%
> F3 (1.48)0.86690.7756-0.958382.60%82.80%83.90%81.40%82.70%
= F4 (1.77)0.91880.8592-0.9784100%85.70%77.50%100%87.70%
APRI
> F2 (0.75)0.81070.7136-0.907775.60%87.50%93.20%61.30%81.50%
> F3 (0.75)0.82720.7140-0.940587%72.40%77.40%83.60%76.50%
= F4 (1.46)0.91430.8387-0.989981.80%90%80.10%91%88.90%
FIB-4
> F2 (1.47)0.86520.7844-0.946178%82.50%91%62.40%80.20%
> F3 (2.0)0.87030.7634-0.977382.60%86.20%86.70%82%85.20%
= F4 (3.91)0.96360.9211-1.00090.90%95.70%91.30%95.50%95.10%